CTO
InnoSIGN, Netherlands
Eveline is the Chief Technology Officer of InnoSIGN. She has over 25 years of experience in the molecular diagnostic assay development field, both in oncology as well as virology. She has a passion for innovation and a deep-seated commitment to advancing healthcare through science. Armed with a strong foundation in molecular biology, Eveline has accumulated a wealth of experience in leading the developing of molecular diagnostic assays, platforms, and technologies including OncoSIGNal technology for profiling of cell signaling pathway activity.